A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis
about
Opposite Interplay between PPAR Gamma and Canonical Wnt/Beta-Catenin Pathway in Amyotrophic Lateral SclerosisAn Overview of Potential Targets for Treating Amyotrophic Lateral Sclerosis and Huntington's DiseaseRisk factors for amyotrophic lateral sclerosisPPARγ as a therapeutic target to rescue mitochondrial function in neurological diseaseALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?Nuclear receptors in neurodegenerative diseases.Expression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primatesConfirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patientsABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis.PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43.Trials of antidiabetic drugs in amyotrophic lateral sclerosis: proceed with caution?Association between diabetes and amyotrophic lateral sclerosis in Sweden.Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study.Complex Inflammation mRNA-Related Response in ALS Is Region DependentIntraspinal stem cell transplantation for amyotrophic lateral sclerosisDiabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study.Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis.PPAR agonists as therapeutics for CNS trauma and neurological diseasesA plural role for lipids in motor neuron diseases: energy, signaling and structure.Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models.Immune system alterations in amyotrophic lateral sclerosis.Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.Innate immune activation in neurodegenerative disease.Role of PPAR γ in the Differentiation and Function of NeuronsA retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies.Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.Simple animal models for amyotrophic lateral sclerosis drug discovery.Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis.The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement.Implications of white matter damage in amyotrophic lateral sclerosis (Review).A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis.Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease.Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis.Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism.Metabolic Dysregulation in Amyotrophic Lateral Sclerosis: Challenges and Opportunities.The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets.The Therapeutic Potential of Metformin in Neurodegenerative Diseases
P2860
Q26742196-2ADE8D8F-EB44-4972-88F9-3AA9BBA4B4E4Q26796027-16299A5E-44B8-4DD7-832B-E98B2098D267Q26827642-18197FA6-9671-4EA2-A836-0E73B9D6EF72Q28069549-EE712F3E-A347-4F3C-AE44-822AC0B9026BQ34554820-23046A7B-9A61-4C05-A6A5-9363DE82A8E2Q34580020-7BA41BC8-FEDF-4FB3-9A93-941AD1AC9068Q34626758-CDEF2A4C-63F7-45CB-9CCC-FFDECFEE313FQ34699979-231E43F5-66A2-459B-9773-B66187BD474BQ35132580-866C802F-A7D8-45B6-99FB-BD2DFC812B0DQ35239387-3040A3E7-FCB9-4814-975C-2717AB28C790Q35618724-F5C2667C-E396-4FE0-8FCB-C977FE7FF151Q35864714-C0F40007-8AD5-40FD-8BAC-C0799CDBAB06Q35891811-FFA4D4E3-6565-45A1-98E4-7804E1C85B98Q35957868-6294C66A-262E-4EE1-AC5C-CB2709F14607Q36679757-89EE4FF0-BA57-40DD-921F-41469106ACD8Q37155949-6B35B61C-FB50-460F-94A9-12D5388EB4A1Q37322677-0046C633-7C1B-4406-9058-D67C905F730AQ37400355-F46279B3-DB54-473A-A31A-7169255867DCQ37594297-7601E12D-5E76-4EC8-A46B-A3040AC423C8Q37686240-5BD5165E-519C-47C5-98EC-78935C96D06DQ38095543-F7143EEF-1DA3-4831-9529-DBC920267431Q38150127-84CC36A6-4041-401F-9A23-4D312BFCC9C5Q38223011-8B16CE47-22FE-479C-AFA4-4EF82ACEB051Q38253356-BAE36152-0199-4173-8D04-A6F78984243DQ38573829-E4A614D8-B4A2-4B8A-A440-C2B14AF157C7Q38633556-102E2888-0721-4A1E-8BC2-E1726523DD46Q38850066-678D5B5B-C0F8-4E57-867D-9604DB3A2366Q39271545-F802B3AA-8C57-4BED-A74C-836E8F542D3CQ41052218-BB8FF700-90E7-4A0E-89DC-793486EA2DE9Q42369773-994DBCC2-965E-48E4-AC63-53D7DB12154AQ42658376-C79E4085-27B7-4B27-8C4A-E8E617416C4DQ46595019-19C0DCB7-97F7-4EFC-8E66-0D36F362DBCEQ47224541-772294C3-BB22-4944-8992-C3157413CE95Q49335981-744FE2C5-477D-4B04-B6AC-AFCB77D00590Q49659203-D62EB22E-A013-4DBE-875A-ED38AE6EB74EQ50066234-41C12854-5673-4EE4-AC89-EC2CFC295822Q55416173-169A5DC7-E23D-4F55-88B1-C3F6EE529AF0Q57175337-690C1BD3-B833-44E3-8B62-8049E797389C
P2860
A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A randomized, double blind, pl ...... amyotrophic lateral sclerosis
@ast
A randomized, double blind, pl ...... amyotrophic lateral sclerosis
@en
A randomized, double blind, pl ...... amyotrophic lateral sclerosis
@nl
type
label
A randomized, double blind, pl ...... amyotrophic lateral sclerosis
@ast
A randomized, double blind, pl ...... amyotrophic lateral sclerosis
@en
A randomized, double blind, pl ...... amyotrophic lateral sclerosis
@nl
prefLabel
A randomized, double blind, pl ...... amyotrophic lateral sclerosis
@ast
A randomized, double blind, pl ...... amyotrophic lateral sclerosis
@en
A randomized, double blind, pl ...... amyotrophic lateral sclerosis
@nl
P2093
P2860
P50
P3181
P1433
P1476
A randomized, double blind, pl ...... amyotrophic lateral sclerosis
@en
P2093
Andrea S Winkler
Andreas Hermann
Bertold Schrank
Carsten Wessig
Eva Lindauer
Franziska Steiner
Jan Kassubek
Jens Dreyhaupt
Luc Dupuis
Markus Otto
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0037885
P407
P577
2012-01-01T00:00:00Z